BCG Update

March 24, 2015
by Monica Smith

Since August, many patients have been experiencing a delay in treatment due to the production of TICE BCG. There has been increased worldwide demand for the drug and few manufacturers causing a backorder issue. Generally, there has been a delay in orders between 2 – 8 weeks which impacts patients, physicians and the entire bladder cancer community.

Read More...

Advocacy Issue – Blue Light Cystoscopy

March 3, 2015
by Monica Smith

You may have read our posting with an update on the issue regarding reimbursement of blue light cystoscopy. As all of you know, there are very few treatments and innovations for bladder cancer. It is BCAN’s position that everyone should have equal access to all treatments, tests and innovations that have been approved by the FDA.

Read More...